Above all I would like to emphasise that oncology is only MARGINAL for my specialty and therefore it is not my priority to deal with its treatments. As part of my assessments when using EAV device, I have found that all the patients tested with Penoxal have responded POSITIVELY so far. This means that the principle of the resonance testing with EAV tells me whether the product is suitable for a patient. The testing does not tell me whether the product will be therapeutic, or when and under what conditions. Hence I am not able to say at this point what the therapeutic results are with Penoxal. I only propose that the resonance of ALL the tested patients with the product resonance were POSITIVE in all cases. Please regard this information as preliminary, it has been confirmed in a relatively small patient sample (up to 10 people).